PGGM Investments - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.

Quarter-by-quarter ownership
PGGM Investments ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$2,374
-28.1%
87,484
-18.6%
0.04%
-24.1%
Q2 2023$3,304
-16.0%
107,487
-1.5%
0.05%
-18.2%
Q1 2023$3,932
-8.8%
109,1250.0%0.07%
-12.0%
Q4 2022$4,313
-99.9%
109,125
+3.0%
0.08%0.0%
Q3 2022$4,257,000
+2418.9%
105,952
+2462.3%
0.08%
+7400.0%
Q2 2021$169,0004,1350.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2022
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders